Aside from the well-known indication of Pemphigus vulgaris, which is treated with therapeutic apheresis techniques, there is sustained and rising interest in IgE-related skin diseases as new candidates for extracorporeal cleaning. The indication of atopic dermatitis is of key interest here, a condition where patients may benefit from the use of adsorption for the purposes of IgE removal.
1. WHO, Bieber T. N Engl J Med Apr. 2008; 358: 142. Meyersburg D, Schmidt E, Kasperkiewicz M, Zillikens D. Immunoadsorption in dermatology. Therapeutic Apheresis and Dialysis Aug. 2012; 16(4): 311–20.
2. Lupinek C et al, Extracorporeal IgE Immunoadsorption in Allergic Asthma: Safety and Efficacy, EBioMedicine, Mar. 2017; 17: 119–33.
3. Eming R, Hertl M. Immunoadsorption in pemphigus. Journal of Autoimmunity Nov. 2006; 39(7): 609–16.